Novartis, Microsoft partner for AI-driven research collaboration

05:43 EDT 3 Oct 2019 | SmartBrief

A new partnership was announced by Novartis and Microsoft that could become a transformative venue for drug discovery and res -More

Original Article: Novartis, Microsoft partner for AI-driven research collaboration


More From BioPortfolio on "Novartis, Microsoft partner for AI-driven research collaboration"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...